Hikma Pharmaceutical | Nettoindtægt



Net Income Lave om Dato
Almirall EUR 7.99M 590K 2024-06
argenx SE USD 774.16M 682.75M 2024-12
AstraZeneca USD 2.92B 1.42B 2025-03
Autolus Therapeutics Ltd -27611000 54.48M 2024-12
Bayer EUR -335000000 3.85B 2024-12
Fresenius EUR 240M 86M 2024-12
Galapagos EUR -153403000 178.71M 2025-03
Genmab DKK 3.84B 2.58B 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
GRIFOLS EUR 68.97M 17.28M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
Lonza CHF 329M 85M 2024-06
Merck EUR 667M 142M 2024-12
Orion EUR 61.2M 12.2M 2025-03
Recordati EUR 113.03M 11.25M 2024-09
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 104M 72M 2024-06



Hikma Pharmaceutical Nettoindtægt - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.